or
forgot password
  • cancer clinical trials in stanford, CA

  • Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Stanford Cancer Center
    Stanford, California 94305-5824
    Breast Cancer
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
    Stanford Cancer Institute
    Stanford, California 94305
    Neuroendocrine Tumors, Carcinoid Tumors
    Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer
    Stanford Cancer Center
    Stanford, California 94305-5824
    Dysphagia, Lung Cancer, Pain, Esophagitis
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
    Stanford Cancer Center
    Stanford, California 94305-5824
    Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma, Marginal Zone Lymphoma
    ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids
    Stanford University Medical Center
    Stanford, California 94305-5408
    Uterine Fibroid(s)
    A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphangioma
    Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
    Stanford University Medical Center, BMT
    Stanford, California 94305
    GVHD, Adult Acute Myeloid Leukemia, Adult Acute Lymphoid Leukemia, Myelodysplastic Syndrome
    Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia
    Stanford Hospital and Clinics
    Stanford, California 94305
    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia, Myelodysplasia
    Safety and Efficacy Study of CAL-101 in Patients With Previously Treated Low-grade Lymphoma
    Stanford Cancer Center
    Stanford, California 94305-5824
    Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Stanford University Hospital
    Stanford, California 94303
    Advanced Prostate Cancer, Prostatic Neoplasms
    A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms
    Stanford Cancer Center
    Stanford, California 94305-5824
    Lymphoma, Large-Cell, Anaplastic, Lymphoma, NK-cell, Lymphoma, T-cell
    Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Graft Versus Host Disease, Systemic Scleroderma
    Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Bone Cancer, Ewing's Sarcoma
    Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Multiple Myeloma
    High Resolution 3D Diffusion-weighted Breast MRI
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer, Carcinoma Breast Stage IV
    SPY Intra-Operative Angiography & Skin Perfusion in Immediate Breast Reconstruction w/ Implants
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer
    A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
    Stanford University Medical Center
    Stanford, California 94305-5408
    Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease, Non-Hodgkin's Lymphoma
    Safety and Efficacy Study of Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Diffuse Large Cell B-lymphoma
    Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Kidney (Renal Cell) Cancer
    A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
    Stanford University Medical Center Stanford Univ 2
    Stanford, California 94304
    Basal Cell Carcinoma
    Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Bone Cancer, Chondrosarcoma, Ewing's Sarcoma, Osteosarcoma, Rhabdomyosarcoma
    Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma
    Stanford University
    Stanford, California 94305
    Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma, Peripheral T-cell Lymphoma
    Patients Treated for SCID (1968-2010)
    Stanford University
    Stanford, California 94305
    SCID, ADA-SCID, XSCID, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    Stanford University Medical Center
    Stanford, California 94305-5408
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma
    Stanford University Hospital
    Stanford, California 94303
    Urothelial Carcinoma
    BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
    Stanford Cancer Center
    Stanford, California 94305-5824
    Renal Cell Carcinoma
    Phase I/II Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Multiple Myeloma
    A Phase II Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Thymoma, Thymus Cancer, Thymic Carcinoma
    A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adults With Myelofibrosis
    Stanford University Medical Center
    Stanford, California 94305-5408
    Myelofibrosis
    Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
    Stanford University Medical Center SC
    Stanford, California 94304
    Cushing's Disease
    Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
    Stanford School of Medicine
    Stanford, California 94305
    Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT
    Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer
    Stanford Cancer Center
    Stanford, California 94305-5824
    Head and Neck Cancer
    Molecular Analysis of Thoracic Malignancies
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Thymus Cancer, Thymoma, Thymic Carcinoma, Lung Cancer, Carcinoma, Non-Small-Cell Lung, Mesothelioma
    A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib
    Stanford Hospital and Clinics
    Stanford, California 94305
    Hepatocellular Carcinoma, Liver Cancer, HCC
    HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer
    Stanford University
    Stanford, California 94305
    Hepatocellular Carcinoma
    Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
    Stanford Cancer Center
    Stanford, California 94305-5824
    Lymphoma
    Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST)
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Gastrointestinal Stromal Tumor (GIST)
    Post T-plant Infusion of Allogeneic Cytokine Induced Killer Cells as Consolidate Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Neural Tube Defects, Anemia, Leukemia, Myeloid, Bone Marrow Transplant Failure, Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders
    Feasibility Study of Exercises for Myeloablative Allogeneic Blood and Marrow Transplantation (BMT) Patients
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Allogenic Disease
    Pilot Study of Brentuximab Vedotin (SGN-35) in Patients With MF With Variable CD30 Expression Level
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma, Non-Hodgkin, Cutaneous Lymphoma, Cutaneous T Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome
    FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma, Lymphoma, Non-Hodgkin, Large B Cell Diffuse Lymphoma
    A Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma
    Stanford Cancer Center
    Stanford, California 94305-5824
    Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell
    Azacitidine + Lenalidomide Combo in the Elderly Previously Treated Acute Myeloid Leukemia (AML) & High-Risk Myelodysplastic Syndromes (MDS)
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
    Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Melanoma
    Adjunctive Application of BioFoam Surgical Matrix in Liver Surgery
    Stanford University Medical Center
    Stanford, California 94305-5408
    Intraoperative Bleeding on Newly Resected Liver Parenchyma
    A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
    Stanford Cancer Center - Stanford University
    Stanford, California 94305
    CD27 Expressing B-cell Malignancies, CD27 Expressing Solid Tumors, Chronic Lymphocytic Leukemia, Burkett's Lymphoma, Mantle Cell Lymphoma, Primary Lymphoma of the Central Nervous System, Marginal Zone B Cell Lymphoma, Solid Tumor, Metastatic Melanoma, Renal (Clear) Cell Carcinoma, Hormone-refractory Prostate Adenocarcinoma, Ovarian Cancer, Colorectal Adenocarcinoma, Non-small Cell Lung Cancer, Melanoma (Solid Tumor Expansion Arm Only)
    Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer
    Stanford University Cancer Institute
    Stanford, California 94305
    Rectal Cancer
    Trial of Individualized Lung Tumor Stereotactic Ablative Radiotherapy (SABR)
    Stanford University Cancer Institute
    Stanford, California 94305
    Lung Cancer
    A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Pancreatic Cancer
    Vitamin D and Breast Cancer: Does Weight Make a Difference?
    Stanford University Cancer Institute
    Stanford, California 94305
    Breast Cancer
    Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, Adult Nodular Sclerosis Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage IV Adult Hodgkin Lymphoma
    Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers
    Stanford University Cancer Institute
    Stanford, California 94305
    Melanoma, Skin
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Colorectal Cancer
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    Stanford Cancer Institute, Stanford University
    Stanford, California 94305
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL
    Stanford University Medical Center
    Stanford, California 94305-5408
    Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia, Precursor T-Cell Lymphoblastic Leukemia
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer
    Stanford University
    Stanford, California 94305
    Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Malignant Tumor of Peritoneum, Stage IV Ovarian Epithelial Cancer, Stage IV Ovarian Germ Cell Tumor
    AMR-001 Versus Placebo Post ST Segment Elevation Myocardial Infarction
    Standford University School of Medicine
    Stanford, California 94305
    ST Segment Elevation Myocardial Infarction